随着以太网技术和集成电路技术的发展,以太网物理层(Physical Layer,PHY)芯片的速率和性能都得到了极大提升,电路复杂度更是几何级增长,以至于常规的自动测试设备(Automatic Test Equipment,ATE)测试很难充分验证其功能,所以亟需开展相...随着以太网技术和集成电路技术的发展,以太网物理层(Physical Layer,PHY)芯片的速率和性能都得到了极大提升,电路复杂度更是几何级增长,以至于常规的自动测试设备(Automatic Test Equipment,ATE)测试很难充分验证其功能,所以亟需开展相应测试方法研究。提出了一种高效的基于ZYNQ MPSOC的以太网PHY芯片功能测试方法。该方法以ZYNQ MPSOC为核心,设计了一种直达应用层面的系统级测试装置,从而减少了与物理层直接交互的行为,有效降低了测试装置及程序开发难度。经试验验证,提出的基于ZYNQ MPSOC的以太网PHY芯片功能测试方法能够用于以太网PHY芯片测试。展开更多
The treatment option for gastric cancer is usually based on preoperative staging by imaging modalities. Endoscopic ultrasonography (EUS) and computed tomography (CT) have been used as the diagnostic modality of choice...The treatment option for gastric cancer is usually based on preoperative staging by imaging modalities. Endoscopic ultrasonography (EUS) and computed tomography (CT) have been used as the diagnostic modality of choice in preoperative staging of gastric cancer. Magnetic resonance imaging (MRI) has been employed in several studies, and (<sup>18</sup>F) 2-Fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) has emerged as a new promising imaging modality. The purpose of this article is to provide summarized information on preoperative staging using EUS, multi-detector row CT (MDCT), MRI and PET for gastric cancer. In T staging, both EUS and MDCT show high accuracy. MRI seemed to have better performance, but the number of MRI studies is limited. FDG-PET is not able to properly evaluate the depth of invasion. In N staging, the diagnostic accuracy of EUS, MDCT and MRI is not sufficient. In preoperative M staging, MDCT and FDG-PET showed similar diagnostic accuracies. FDG-PET/CT fusion could be expected to show better performance in the future. Physicians should keep in mind that each diagnostic modality has advantages and limitations and choose an appropriate diagnostic strategy tailored for each patient.展开更多
文摘The treatment option for gastric cancer is usually based on preoperative staging by imaging modalities. Endoscopic ultrasonography (EUS) and computed tomography (CT) have been used as the diagnostic modality of choice in preoperative staging of gastric cancer. Magnetic resonance imaging (MRI) has been employed in several studies, and (<sup>18</sup>F) 2-Fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) has emerged as a new promising imaging modality. The purpose of this article is to provide summarized information on preoperative staging using EUS, multi-detector row CT (MDCT), MRI and PET for gastric cancer. In T staging, both EUS and MDCT show high accuracy. MRI seemed to have better performance, but the number of MRI studies is limited. FDG-PET is not able to properly evaluate the depth of invasion. In N staging, the diagnostic accuracy of EUS, MDCT and MRI is not sufficient. In preoperative M staging, MDCT and FDG-PET showed similar diagnostic accuracies. FDG-PET/CT fusion could be expected to show better performance in the future. Physicians should keep in mind that each diagnostic modality has advantages and limitations and choose an appropriate diagnostic strategy tailored for each patient.
